Dympal Jain Discloses Open Market Purchase of Amanta Healthcare Equity Shares
Amanta Healthcare Limited announced the receipt of a disclosure form from Dympal Jain, an immediate relative to Director Nitin Jain, detailing an open market purchase of equity shares. The disclosure, received March 25, 2026, is in accordance with the Securities and Exchange Board of India (SEBI) (Prohibition of Insider Trading) Regulations, 2015.According to the disclosure, Ms. Jain acquired 15,675 equity shares between March 19, 2026 and March 24, 2026. The total value of the acquisition was ₹15,01,041.13. Following the purchase, Ms. Jain’s holding in the company comprises 15,676 equity shares, representing 0.04% of the total outstanding shares. The transactions were executed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
Summary of Acquisition
| Detail | Value |
|---|---|
| Securities | Equity Shares |
| Number of Shares Acquired | 15,675 |
| Total Value | ₹15,01,041.13 |
| Shares Held Post Acquisition | 15,676 |
| Percentage of Shares Held | 0.04% |
| Acquisition Period | March 19 - 24, 2026 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.